Đang chuẩn bị liên kết để tải về tài liệu:
Optimal treatment and prognostic factors for esthesioneuroblastoma: Retrospective analysis of 187 Chinese patients

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The standard treatment for esthesioneuroblastoma, a rare malignant nasal vault neoplasm, is not established. Methods: We retrospectively assessed the clinicopathological features, prognostic factors and treatment methods for 187 patients with esthesioneuroblastoma treated in China between 1981 and 2015. Overall survival (OS) and disease-free survival (DFS) were evaluated using the Kaplan-Meier method and log-rank tests. |

TÀI LIỆU LIÊN QUAN

The rapid kinetics of optimal treatment with subcutaneous methotrexate in early inflammatory arthritis: An observational study

The use of water spinach (Ipomoea aquatica) domestic wastewater treatment

Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: A retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy

Neoadjuvant chemotherapy and radiotherapy followed by resection/ ablation in stage IV rectal cancer patients with potentially resectable metastases

Modeling Simulation and Optimization Tolerance and Optimal Control

Báo cáo khoa học: " Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans"

WATER REUSE IN PAPER MILLS MEASUREMENTS AND CONTROL PROBLEMS IN BIOLOGICAL TREATMENT

Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma

Achieving optimal response at 12 months is associated with a better health-related quality of life in patients with chronic myeloid leukemia: A prospective, longitudinal, single center study

Motor unit number index detects the effectiveness of surgical treatment in improving distal motor neuron loss in patients with incomplete cervical spinal cord injury